ArticleCancer2025

Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study.

Mina Fazel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.